Loading the security overview…
Where the tokens are
| Settlement | Shares short | Average daily volume | Days to cover |
|---|---|---|---|
| Sep 15, 2026 | 4.96M | 924.05K | 5.37 |
| Aug 31, 2026 | 5.06M | 1.09M | 4.65 |
| Aug 14, 2026 | 4.55M | 1.33M | 3.42 |
| Jul 31, 2026 | 4.39M | 1.46M | 3.01 |
| Jul 15, 2026 | 5.33M | 1.09M | 4.91 |
| Jun 30, 2026 | 5.53M | 1.32M | 4.20 |
| Jun 15, 2026 | 5.69M | 1.13M | 5.04 |
| May 29, 2026 | 5.53M | 1.11M | 4.96 |
| May 15, 2026 | 5.16M | 1.4M | 3.69 |
| Apr 30, 2026 | 5.99M | 1.16M | 5.15 |
| Apr 15, 2026 | 5.64M | 1.16M | 4.86 |
| Mar 31, 2026 | 4.56M | 982.23K | 4.64 |
The share of each day’s reported trading that was a short sale. This is not short interest: most of it is market makers selling short to fill buy orders and buying back within the day, so a ratio of 30–50% is ordinary for a heavily traded stock and says little about how many shares are held short overnight.
Figures describe Neurocrine Biosciences shares, not any token. As of Sep 15, 2026, from exchange short-interest reports and FINRA short-sale volume, via Massive. Short sellers borrow and sell the shares themselves; token holders are not lending theirs.